Responses
Regular and young investigator award abstracts
Immunotherapy toxicities
645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis
Compose a Response to This Article
Other responses
No responses have been published for this article.
